Summary
Introduction
Vitamin D is an important factor for bone metabolism and neuromuscular function [1] . Vitamin D supplementation is effective in lowering the risk of fall and fracture in elderly subjects [2, 3] . Some experts recommend a level higher than 30 ng/ml (75 nmol/l) for high-risk patients [4] [5] [6] . There is an overall consensus among scientific organisations that levels higher than 20 ng/ml (50 nmol/l) are necessary for bone and muscular health [7] [8] [9] . Old and recent studies have already shown a high prevalence of hypovitaminosis D in Switzerland [10, 11] , and a few studies have also underlined this problem among rheumatology outpatients [12, 13] . We have shown that hypovitaminosis D was highly prevalent in an outpatient population of Swiss rheumatology patients, affecting 86% of subjects in 2009 [14] . This situation could be explained by different causes: lack of sufficient sunshine, sun avoidance in older patients or patients with photosensitivity, inadequate clinician and patient information, infrequent screening and suboptimal adherence to daily substitution or insufficient supplementation. Therefore we aimed to evaluate the evolution of vitamin D status in the same outpatient rheumatology population two years later, after the results of the first study were widely disseminated to local physicians and patients, to determine the evolution of the problem and the impact of physician information.
Method
We evaluated the prevalence of hypovitaminosis D in an outpatient population attending the rheumatology clinic of the University Hospital of Lausanne in November 2009 [14] . Between November 2009 and October 2011, we informed and sensitised local physicians about the risks and the management of hypovitaminosis D and presented results of this first study. Next, we repeated the same screening in November 2011. All patients in our rheumatology clinic were offered a screening test for 25-OH vitamin D. The results were categorised as: deficient (<10 ng/ml or <25 nmol/l), insufficient (10 to 30 ng/ml or 25 to 75 nmol/ l) or normal (>30 ng/ml or >75 nmol/l). We also used the more recently recommended cut-off of 20 ng/ml (50 nmol/ l) and revaluate the 2011 and 2009 populations with it. Vitamin D levels were determined using radioimmunological assay with extraction (25-hydroxyvitamin D 125 I RIA Kit, DiaSorin ® ). Patients were asked about their calcium and vitamin D supplementation. We compared the results with those of November 2009 after exclusion of patients who were not regularly followed in our clinic and those who received a high dose (300,000 IU) of oral or intramuscular vitamin D in the previous six months in both screening populations. We asked the central laboratory and pharmacy of our university hospital about the evolution of 25-OH vitamin D dosages and vitamin D3 prescriptions between 2008 and 2011. Finally, to try and determine the impact of local physician education, we evaluated the number of publications on vitamin D in the three most important Swiss medical journals of the French speaking part of Switzerland. We searched for publications with the word "vitamin D" in Swiss Medical Weekly, Swiss Medical Forum and La Revue Médicale de la Suisse Romande.
Statistical analysis
We tested for normal distribution of the results by ShapiroWilk and Shapiro-Francia tests for normality. All results were normally distributed. To compare proportions, we performed a Chi square test. To compare vitamin D level between the two unpaired samples, we performed a t-test for unpaired measurement. A p-value <0.05 was considered significant.
Results
A total of 336 patients were screened in 2011. We excluded 37 patients who received a high dose of vitamin D in the six months preceding the study and 60 patients who were not regularly followed up in our clinic between 2009 
Discussion
Prevalence of hypovitaminosis D decreased in two years from 86% to 72% (or from 48% to 34% using the cut-off of 20 ng/ml) despite the fact that the population was older in 2011. These results were mainly due to the higher num- It could also be related to higher prescription of high doses of vitamin D3 supplement in the previous years in our department particularly in the nonsupplemented patients. Of note, this kind of supplementation has been shown to be efficient in selected cases despite some controversy concerning its safety [15] . It is also reasonable to think that patients not receiving regular prescriptions for vitamin D were simply more aware of the problem of hypovitaminosis D and took more regular natural supplement, in food for example. Our study has many limitations. Firstly, it is an uncontrolled study. Secondly, the two populations compared are different. Thirdly, we did not perform a specific verification of compliance with daily vitamin D supplementation. Finally we could not determine precisely which patients benefited from prescription of high doses of vitamin D3 between December 2009 and April 2011 (incomplete files). Therefore we cannot demonstrate the proposed relation between the increase in adherence with daily supplement and the prescription of high doses of vitamin D and the better results in 2011. Our study has nevertheless some strengths. Interestingly we could show a significant increase in vitamin D levels despite the older age and decreased sun exposure. Most importantly it is a true population-based study and the two populations are very similar. We used the same dosage method and we did the blood tests at the same time of the year (same month) at the same policlinic (same place). And finally it gives a simple and strong message about the possibility of improving the vitamin D status in a population with better physician information and patient education. It is indeed very important to improve our capacity to supplement a rheumatology population considering the wellknown relationship between hypovitaminosis D and musculoskeletal health and the increasing evidences of a correlation between the activity of autoimmune rheumatic disease and vitamin D status [16] [17] [18] .
In conclusion, the prevalence of low vitamin D decreased in two years from 86% to 72%. These results were mainly due to the higher number of normal 25-OH vitamin D levels observed in patients taking oral daily vitamin D (increasing from 25% to 51%). These results may be explained by: 1) better adherence to oral daily vitamin D in the supplemented patients; 2) better information of physicians about hypovitaminosis D; 3) more frequent screening of vitamin D level and 4) higher prescription of high doses of vitamin D if this is deemed needed. Funding / potential competing interests: No financial support and no other potential conflict of interest relevant to this article was reported.
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